Tue, August 8, 2017
Mon, August 7, 2017
Fri, August 4, 2017
Thu, August 3, 2017
Wed, August 2, 2017
Tue, August 1, 2017
Mon, July 31, 2017
Fri, July 28, 2017
Thu, July 27, 2017
Wed, July 26, 2017
Tue, July 25, 2017
Mon, July 24, 2017
Fri, July 21, 2017
Thu, July 20, 2017
Wed, July 19, 2017
Tue, July 18, 2017

Vincent Chen Initiated (BLUE) at Hold and Held Target at $109 on, Jul 27th, 2017

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. old-and-held-target-at-109-on-jul-27th-2017.html
  Print publication without navigation Published in Stocks and Investing on
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Vincent Chen of Bernstein, Initiated "bluebird bio, Inc." (BLUE) at Hold and Held Target at $109 on, Jul 27th, 2017.

Vincent has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 2 agree with Vincent's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $103 on, Monday, July 10th, 2017
  • Dane Leone of "BTIG" Downgraded from Strong Buy to Hold on, Friday, June 30th, 2017


This is the rating of the analyst that currently disagrees with Vincent


  • Matthew Luchini of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $108 on, Tuesday, June 6th, 2017